HIV/AIDS in Europe
Open-knowledge reference entry
In Western Europe, the routes of transmission of HIV are diverse, including paid sex, sex between men, intravenous drugs, mother to child transmission, and heterosexual sex. However, many new infections in this region occur through contact with HIV-infected individuals from other regions. In some areas of Europe, such as the Baltic countries, the most common route of HIV transmission is through injecting drug use and heterosexual sex, including paid sex.
The adult (15–49) prevalence in Europe in 2018 varied from a high of 1.20% in Russia to a low of 0.1% in eleven countries. Due to the availability of antiretroviral therapy, deaths from AIDS have stayed low since the introduction of protease inhibitors and combination therapy in the late 1990s. 14% are believed to have been infected by intravenous drug use in 2018.
Regarding the social effects of the HIV/AIDS pandemic, there has been since the 1980s a "profound re-medicalization of sexuality".
Albania
Albania has a low-prevalence HIV epidemic compared to many other European countries, though recent trends show a gradual increase in new infections and concerns about late diagnosis. Between 1993 and 2023, a total of 1,716 individuals were diagnosed with HIV, including 113 new cases in 2023. The estimated number of people living with HIV (PLHIV) is approximately 1,600 [1,300–1,800].
The public source identifies “HIV/AIDS in Europe” as open-knowledge reference entry. This brief keeps that definition visible, then builds a research path around AIDS, Europe and Open-knowledge.
Why this record matters
A short description can identify a subject without explaining its stakes. For “HIV/AIDS in Europe”, the useful work is to connect “open-knowledge reference entry” to the records capable of establishing context and consequence.
Vocabulary and entity names are the principal evidence signals here, because they determine the precision of every later search. The source revision retrieved here is dated Jan 9, 2026. The linked authority identifier is Q3483100. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2018, 1993 and 2023.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “HIV/AIDS in Europe”, its source revision and the description used here.
- Expand the search: follow HIV/AIDS in Europe primary sources, HIV/AIDS in Europe archive and AIDS research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “HIV/AIDS in Europe”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “HIV/AIDS in Europe” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.